James M. Rolke
2017
In 2017, James M. Rolke earned a total compensation of $2M as Chief Scientific Officer at La Jolla Pharmaceutical.
Compensation breakdown
| Non-Equity Incentive Plan | $175,000 |
|---|---|
| Option Awards | $1,455,057 |
| Salary | $350,000 |
| Other | $16,613 |
| Total | $1,996,670 |
Rolke received $1.5M in option awards, accounting for 73% of the total pay in 2017.
Rolke also received $175K in non-equity incentive plan, $350K in salary and $16.6K in other compensation.
Rankings
In 2017, James M. Rolke's compensation ranked 5,510th out of 14,666 executives tracked by ExecPay. In other words, Rolke earned more than 62.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,510 out of 14,666 | 62nd |
Division Manufacturing | 1,983 out of 5,770 | 66th |
Major group Chemicals And Allied Products | 600 out of 2,074 | 71st |
Industry group Drugs | 462 out of 1,730 | 73rd |
Industry Biological Products, Except Diagnostic Substances | 87 out of 316 | 73rd |
Source: SEC filing on August 22, 2018.
Rolke's colleagues
We found four more compensation records of executives who worked with James M. Rolke at La Jolla Pharmaceutical in 2017.